Clinical Trial Update: Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial of Tobramycin Inhalation Powder for cystic fibrosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Tobramycin Inhalation Powder (tobramycin inhalation powder)

Snippet

Sponsor: Novartis | Conditions: Cystic Fibrosis | Phase 3 | Status: TERMINATED